FHR4-based complement-activating multimeric immunotherapeutic complexes (COMIX) inhibit tumor growth of HER2-expressing xenografts in nude mice

Carole Devaux, Quentin Etienne, Jacques H. M. Cohen, Xavier Dervillez

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Article number124
Pages (from-to)456-457
JournalMolecular Immunology
Publication statusPublished - Oct 2019
Event17th European Meeting on Complement in Human Disease (EMCHD) - Madrid, Spain
Duration: 14 Sept 201917 Sept 2019

Cite this